Policy Number

NSHA CAN-ST-005

NSHA CAN-ST-005 Biosimilars in Oncology

Description

This policy directive will define when oncology biosimilars are to be used in clinical practice in NSHA. It determines the selection of and funding for biosimilar and reference biologics.